特集 : 国別レポートが13,000件から検索可能になりました!

特集 : 海外市場の委託調査がセミカスタムベースでお手軽にできます

株式会社グローバルインフォメーション
表紙
市場調査レポート
商品コード
521287

ED (勃起不全) の世界市場:製品別、地域別 - 考察、市場機会分析、将来予測

Erectile Dysfunction Market, By Product, and Geography - Insights, Opportunity Analysis, and Industry Forecast till 2024

出版日: | 発行: Coherent Market Insights | ページ情報: 英文 152 Pages | 納期: 2-3営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=106.45円
ED (勃起不全) の世界市場:製品別、地域別 - 考察、市場機会分析、将来予測
出版日: 2017年04月04日
発行: Coherent Market Insights
ページ情報: 英文 152 Pages
納期: 2-3営業日
  • 全表示
  • 概要
  • 目次
概要

当レポートでは、世界の勃起不全 (ED) 治療薬の市場について分析し、市場の基本構造や促進・抑制要因、全体的な市場規模・市場シェア・成長率の動向見通し (過去3年間・今後8年間分)、製品別・地域別の詳細動向、市場競争状況 (企業間の相互比較)、主要企業のプロファイル・業績・戦略展開状況などを調査しております。

第1章 分析目的と前提条件

第2章 市場の範囲

第3章 市場のダイナミクス、規制、動向分析

  • 市場のダイナミクス
    • 市場促進要因
    • 市場抑制要因
    • 市場機会
  • 価格動向シナリオ
  • PEST分析
  • キャンペーン・プログラム
  • 流通チャネル
  • パイプライン治療薬
  • 有病者数・発症件数

第4章 世界のED市場:製品別

  • イントロダクション
    • 市場シェア分析 (実績値・予測値)
    • 年間成長率の分析 (通算11年間分)
    • 手法別の市場動向
  • バイアグラ
    • イントロダクション
    • 市場規模とその予測、年間成長率:金額ベース (通算11年間分)
  • Cialis
  • Stendra/Sperda
  • Levitra/Staxyn
  • Zydena
  • Vitaros

第5章 世界のED市場:地域別

  • イントロダクション
  • 北米市場
    • 市場シェア分析:国別 (実績値・予測値)
    • 年間成長率の分析:国別 (通算11年間分)
    • 米国市場
    • カナダ市場
  • 欧州市場
    • 英国市場
    • ドイツ市場
    • イタリア市場
    • フランス市場
    • スペイン市場
    • ロシア市場
    • その他の市場
  • アジア太平洋地域市場
    • 中国市場
    • インド市場
    • 日本市場
    • ASEAN諸国市場
    • オーストラリア市場
    • 韓国市場
    • その他の市場
  • ラテンアメリカ市場
    • ブラジル市場
    • メキシコ市場
    • アルゼンチン市場
    • その他の市場
  • 中東市場
    • 湾岸協力会議 (GCC) 諸国市場
    • イスラエル市場
    • その他の市場
  • アフリカ市場
    • 北アフリカ
    • 中部アフリカ
    • 南アフリカ

第7章 競争環境

  • ヒートマップ分析
  • 企業プロファイル
    • Meda Pharmaceuticals, Inc
      • 企業概要
      • 製品ポートフォリオ
      • 財務実績
      • 近年の動向
      • 将来計画
    • Coloplast
    • Global Life Technologies
    • Reflexonic, LLC
    • Augusta Medical System
    • Boston Scientific Corporation
    • Vivus, Inc
  • アナリストの見解

第7章 付録

目次

Erectile dysfunction is a sexual disorder characterized by the failure of a male individual to develop and maintain an erection of the penis during coitus. A penile erection is the process affecting the blood flow and reserve in sponge-like bodies within the penis. This causes arterial dilation, trabecular smooth muscle relaxation, and activation of the corporeal veno-occlusive mechanism. According to a Massachusetts Male Aging Study (MMAS) conducted by the European Association in 2015, the incidence of erectile dysfunction is 52% in non-institutionalized men in the urban and rural areas of Boston. In a cohort study by the MMAS, it was observed that one in four men seeking medical help for treating erectile dysfunction is above 40 years of age, with nearly 50% diagnosed with severe erectile dysfunction.

Market Dynamics

North America and Asia Pacific are the largest markets for erectile dysfunction products, as these regions have the highest prevalence of erectile dysfunction. For instance in the year 2012, according to The Massachusetts study, approximately 19,372 new cases of erectile dysfunction in Massachusetts and more than 721,615 cases in the United States yearly. China has a prevalence percentage of about 42.3 in the year 2011. There are many studies conducted to develop medication and medical devices to treat erectile dysfunction. According to the National Institutes of Health, over 30 million men over 75 years of age suffer from erectile dysfunction in the U.S. The Multinational Survey on the Aging Male (MSAM) study conducted in the U.S. and in European countries such as France, Germany, Italy, Netherlands, Spain, and the U.K. arrived at an unexplained relationship between lower urinary tract symptoms and sexual dysfunction in over 12 thousand men in the age group of 50-80 years. Of the 83% of the male population that was surveyed, who claimed to be sexually-active all the time, overall prevalence of lower urinary tract symptoms was 90%, with an overall incidence of erectile dysfunction pegged at 50%, and 10% of patients reported a complete absence of erection. Moreover, the overall incidence of ejaculation disorders was 46%.

Market Taxonomy

This report segments the global erectile dysfunction market on the basis of product, end user and geography. On the basis of product, the market is categorized into Viagra, Cialis, Stendra/ Spedra, Levitra, Zydena, and Vitaros. On the basis of end user, the market is categorized into hospitals, laboratories, homecare diagnostics, research institutes, and others. For comprehensive understanding of market dynamics, the global erectile dysfunction market is analyzed across key geographical regions namely North America, Europe, Asia Pacific, Latin America, Africa, and Middle East. Each of these regions is analyzed on basis of market findings across major countries in these regions for a macro-level understanding of the market.

Key features of the study:

  • This report provides in-depth analysis of the erectile dysfunction market size (US$ Million) and Cumulative Annual Growth Rate (CAGR (%)) for the forecast period: 2016 - 2024, considering 2015 as the base year
  • It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategy adopted by the leading players
  • It profiles leading players in the global erectile dysfunction market based on the following parameters - company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments and strategies and future plans
  • Key companies covered as a part of this study include Meda Pharmaceuticals, Inc., Coloplast, Global Life Technologies, Reflexonic, LLC, Augusta Medical System, Boston Scientific Corporation, and Vivus, Inc.
  • Insights from this report would allow marketers and management authorities of companies to make informed decision with respect to their future product launch, end user upgrades, market expansion, and marketing tactics
  • The global erectile dysfunction market report caters to various stakeholders in this industry, including investors, drug manufacturers, distributors and suppliers for erectile dysfunction products, research and consulting firms, new entrants, and financial analysts
  • Various strategy matrices used in analyzing the erectile dysfunction market would provide stakeholders vital inputs to make strategic decisions accordingly

Detailed Segmentation:

  • Global Erectile Dysfunction Market, By Product:
    • Viagra (Sildenafil citrate)
    • Cialis (Tadalafil)
    • Stendra/Spedra
    • Levitra/Staxyn
    • Zydena (Udenafil)
    • Vitaros (Alprostadil Cream)
  • Global Erectile Dysfunction Market, By Geography:
    • North America
      • U.S.
      • U.S. Erectile Dysfunction Market, By Product:
      • Viagra (Sildenafil citrate)
      • Cialis (Tadalafil)
      • Stendra/Spedra
      • Levitra/Staxyn
      • Zydena (Udenafil)
      • Vitaros (Alprostadil Cream)
      • Canada
      • Canada Erectile Dysfunction Market, By Product:
      • Viagra (sildenafil citrate)
      • Cialis (Tadalafil)
      • Stendra/Spedra
      • Levitra/Staxyn
      • Zydena (udenafil)
      • Vitaros (Alprostadil Cream)
    • Europe
      • U.K.
      • U.K. Erectile Dysfunction Market, By Product:
      • Viagra (sildenafil citrate)
      • Cialis (Tadalafil)
      • Stendra/Spedra
      • Levitra/Staxyn
      • Zydena (udenafil)
      • Vitaros (Alprostadil Cream)
      • Germany
      • Germany Erectile Dysfunction Market, By Product:
      • Viagra (sildenafil citrate)
      • Cialis (Tadalafil)
      • Stendra/Spedra
      • Levitra/Staxyn
      • Zydena (udenafil)
      • Vitaros (Alprostadil Cream)
      • Italy
      • Italy Erectile Dysfunction Market, By Product:
      • Viagra (sildenafil citrate)
      • Cialis (Tadalafil)
      • Stendra/Spedra
      • Levitra/Staxyn
      • Zydena (udenafil)
      • Vitaros (Alprostadil Cream)
      • France
      • France Erectile Dysfunction Market, By Product:
      • Viagra (sildenafil citrate)
      • Cialis (Tadalafil)
      • Stendra/Spedra
      • Levitra/Staxyn
      • Zydena (udenafil)
      • Vitaros (Alprostadil Cream)
      • Spain
      • Spain Erectile Dysfunction Market, By Product:
      • Viagra (sildenafil citrate)
      • Cialis (Tadalafil)
      • Stendra/Spedra
      • Levitra/Staxyn
      • Zydena (udenafil)
      • Vitaros (Alprostadil Cream
      • Russia
      • Russia Erectile Dysfunction Market, By Product:
      • Viagra (sildenafil citrate)
      • Cialis (Tadalafil)
      • Stendra/Spedra
      • Levitra/Staxyn
      • Zydena (udenafil)
      • Vitaros (Alprostadil Cream)
      • Rest of Europe
      • Rest of Europe Erectile Dysfunction Market, By Product:
      • Viagra (sildenafil citrate)
      • Cialis (Tadalafil)
      • Stendra/Spedra
      • Levitra/Staxyn
      • Zydena (udenafil)
      • Vitaros (Alprostadil Cream)
    • Asia Pacific
      • China
      • China Erectile Dysfunction Market, By Product:
      • Viagra (sildenafil citrate)
      • Cialis (Tadalafil)
      • Stendra/Spedra
      • Levitra/Staxyn
      • Zydena (udenafil)
      • Vitaros (Alprostadil Cream)
      • India
      • India Erectile Dysfunction Market, By Product:
      • Viagra (sildenafil citrate)
      • Cialis (Tadalafil)
      • Stendra/Spedra
      • Levitra/Staxyn
      • Zydena (udenafil)
      • Vitaros (Alprostadil Cream)
      • Japan
      • Japan Erectile Dysfunction Market, By Product:
      • Viagra (sildenafil citrate)
      • Cialis (Tadalafil)
      • Stendra/Spedra
      • Levitra/Staxyn
      • Zydena (udenafil)
      • Vitaros (Alprostadil Cream)
      • ASEAN
      • ASEAN Erectile Dysfunction Market, By Product:
      • Viagra (sildenafil citrate)
      • Cialis (Tadalafil)
      • Stendra/Spedra
      • Levitra/Staxyn
      • Zydena (udenafil)
      • Vitaros (Alprostadil Cream)
      • Australia
      • Australia Erectile Dysfunction Market, By Product:
      • Viagra (sildenafil citrate)
      • Cialis (Tadalafil)
      • Stendra/Spedra
      • Levitra/Staxyn
      • Zydena (udenafil)
      • Vitaros (Alprostadil Cream)
      • South Korea
      • South Korea Erectile Dysfunction Market, By Product:
      • Viagra (sildenafil citrate)
      • Cialis (Tadalafil)
      • Stendra/Spedra
      • Levitra/Staxyn
      • Zydena (udenafil)
      • Vitaros (Alprostadil Cream)
      • Rest of Asia Pacific
      • Rest of Asia Pacific Erectile Dysfunction Market, By Product:
      • Viagra (sildenafil citrate)
      • Cialis (Tadalafil)
      • Stendra/Spedra
      • Levitra/Staxyn
      • Zydena (udenafil)
      • Vitaros (Alprostadil Cream)
    • Latin America
      • Brazil
      • Brazil Erectile Dysfunction Market, By Product:
      • Viagra (sildenafil citrate)
      • Cialis (Tadalafil)
      • Stendra/Spedra
      • Levitra/Staxyn
      • Zydena (udenafil)
      • Vitaros (Alprostadil Cream)
      • Mexico
      • Mexico Erectile Dysfunction Market, By Product:
      • Viagra (sildenafil citrate)
      • Cialis (Tadalafil)
      • Stendra/Spedra
      • Levitra/Staxyn
      • Zydena (udenafil)
      • Vitaros (Alprostadil Cream)
      • Rest of Latin America
      • Rest of Latin America Erectile Dysfunction Market, By Product:
      • Viagra (sildenafil citrate)
      • Cialis (Tadalafil)
      • Stendra/Spedra
      • Levitra/Staxyn
      • Zydena (udenafil)
      • Vitaros (Alprostadil Cream)
    • Middle East
      • GCC
      • GCC Erectile Dysfunction Market, By Product:
      • Viagra (sildenafil citrate)
      • Cialis (Tadalafil)
      • Stendra/Spedra
      • Levitra/Staxyn
      • Zydena (udenafil)
      • Vitaros (Alprostadil Cream)
      • Israel
      • Israel Erectile Dysfunction Market, By Product:
      • Viagra (sildenafil citrate)
      • Cialis (Tadalafil)
      • Stendra/Spedra
      • Levitra/Staxyn
      • Zydena (udenafil)
      • Vitaros (Alprostadil Cream)
      • Rest of Middle East
      • Rest of Middle East Erectile Dysfunction Market, By Product:
      • Viagra (sildenafil citrate)
      • Cialis (Tadalafil)
      • Stendra/Spedra
      • Levitra/Staxyn
      • Zydena (udenafil)
      • Vitaros (Alprostadil Cream)
    • Africa
      • North Africa
      • North Africa Erectile Dysfunction Market, By Product:
      • Viagra (sildenafil citrate)
      • Cialis (Tadalafil)
      • Stendra/Spedra
      • Levitra/Staxyn
      • Zydena (udenafil)
      • Vitaros (Alprostadil Cream)
      • Central Africa
      • Central Africa Erectile Dysfunction Market, By Product:
      • Viagra (sildenafil citrate)
      • Cialis (Tadalafil)
      • Stendra/Spedra
      • Levitra/Staxyn
      • Zydena (udenafil)
      • Vitaros (Alprostadil Cream)
      • South Africa
      • South Africa Erectile Dysfunction Market, By Product:
      • Viagra (sildenafil citrate)
      • Cialis (Tadalafil)
      • Stendra/Spedra
      • Levitra/Staxyn
      • Zydena (udenafil)
      • Vitaros (Alprostadil Cream)
  • Company Profiles
    • Meda Pharmaceuticals, Inc *
      • Company Overview
      • Product Portfolio
      • Financial Performance
      • Key Strategies
      • Recent Developments
      • Future Plans
    • Coloplast
    • Global Life Technologies
    • Reflexonic, LLC
    • Augusta Medical System
    • Boston Scientific Corporation
    • Vivus, Inc
  • "*" marked represents similar segmentation in other categories in the respective section.

Table of Contents

1. Research Objective and assumption

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snippet By Product
    • Market Snippet By Geography
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
    • Supply Side Drivers
    • Demand Side Drivers
    • Economic Drivers
    • Restraints
    • Market Opportunities
  • Pricing Scenario
  • PEST Analysis
  • Campaigns and Programs
  • Distribution Channel
  • Pipeline Drugs
  • Prevalence and Incidence

4. Global Erectile Dysfunction Market, By Product, 2014 - 2024 (US$ Million)

  • Introduction
    • Market Share Analysis, 2015 and 2024 (%)
    • Y-O-Y Growth Analysis, 2014 - 2024
    • Segment Trends
  • Viagra
    • Introduction
    • Market Size and Forecast, and Y-O-Y Growth, 2014 - 2024, (US$ Million)
    • Segment Trend
    • Market Size and Forecast, and Y-o-Y Growth Analysis, 2014 -2024
  • Cialis
    • Introduction
    • Market Size and Forecast, and Y-O-Y Growth, 2014 - 2024, (US$ Million)
    • Segment Trend
    • Market Size and Forecast, and Y-o-Y Growth Analysis, 2014 -2024
  • Stendra/Sperda
    • Introduction
    • Market Size and Forecast, and Y-O-Y Growth, 2014 - 2024, (US$ Million)
    • Segment Trend
    • Market Size and Forecast, and Y-o-Y Growth Analysis, 2014 -2024
  • Levitra/Staxyn
    • Introduction
    • Market Size and Forecast, and Y-O-Y Growth, 2014 - 2024, (US$ Million)
    • Segment Trend
    • Market Size and Forecast, and Y-o-Y Growth Analysis, 2014 -2024
  • Zydena
    • Introduction
    • Market Size and Forecast, and Y-O-Y Growth, 2014 - 2024, (US$ Million)
    • Segment Trend
    • Market Size and Forecast, and Y-o-Y Growth Analysis, 2014 -2024
  • Vitaros
    • Introduction
    • Market Size and Forecast, and Y-O-Y Growth, 2014 - 2024, (US$ Million)
    • Segment Trend
    • Market Size and Forecast, and Y-o-Y Growth Analysis, 2014 -2024

5. Global Erectile Dysfunction Market, By Geography, 2014 - 2024 (US$ Million)

  • Introduction
    • Market Share Analysis, By Region, 2015 and 2024 (%)
    • Y-O-Y Growth Analysis, For Regions, 2014 - 2024
  • North America
    • Market Share Analysis, By Country, 2015 and 2024 (%)
    • Y-O-Y Growth Analysis, By Country, 2014 - 2024
    • U.S.
    • Country Trends
    • Market Size and Forecast, By Product, 2014 - 2024 (US$ Million)
    • Canada
    • Country Trends
    • Market Size and Forecast, By Product, 2014 - 2024 (US$ Million)
  • Europe
    • Market Share Analysis, By Country, 2015 and 2024 (%)
    • Y-O-Y Growth Analysis, By Country, 2014 - 2024
    • U.K.
    • Country Trends
    • Market Size and Forecast, By Product, 2014 - 2024 (US$ Million)
    • Germany
    • Country Trends
    • Market Size and Forecast, By Product, 2014 - 2024 (US$ Million)
    • Italy
    • Country Trends
    • Market Size and Forecast, By Product, 2014 - 2024 (US$ Million)
    • France
    • Country Trends
    • Market Size and Forecast, By Product, 2014 - 2024 (US$ Million)
    • Spain
    • Country Trends
    • Market Size and Forecast, By Product, 2014 - 2024 (US$ Million)
    • Russia
    • Country Trends
    • Market Size and Forecast, By Product, 2014 - 2024 (US$ Million)
    • Rest of Europe
    • Country Trends
    • Market Size and Forecast, By Product, 2014 - 2024 (US$ Million)
  • Asia Pacific
    • Market Share Analysis, By Country, 2015 and 2024 (%)
    • Y-O-Y Growth Analysis, By Country, 2014 - 2024
    • China
    • Country Trends
    • Market Size and Forecast, By Product, 2014 - 2024 (US$ Million)
    • India
    • Country Trends
    • Market Size and Forecast, By Product, 2014 - 2024 (US$ Million)
    • Japan
    • Country Trends
    • Market Size and Forecast, By Product, 2014 - 2024 (US$ Million)
    • ASEAN
    • Country Trends
    • Market Size and Forecast, By Product, 2014 - 2024 (US$ Million)
    • Australia
    • Country Trends
    • Market Size and Forecast, By Product, 2014 - 2024 (US$ Million)
    • South Korea
    • Country Trends
    • Market Size and Forecast, By Product, 2014 - 2024 (US$ Million)
    • Rest of Asia Pacific
    • Country Trends
    • Market Size and Forecast, By Product, 2014 - 2024 (US$ Million)
  • Latin America
    • Market Share Analysis, By Country, 2015 and 2024 (%)
    • Y-O-Y Growth Analysis, By Country, 2014 - 2024
    • Brazil
    • Country Trends
    • Market Size and Forecast, By Product, 2014 - 2024 (US$ Million)
    • Mexico
    • Country Trends
    • Market Size and Forecast, By Product, 2014 - 2024 (US$ Million)
    • Argentina
    • Country Trends
    • Market Size and Forecast, By Product, 2014 - 2024 (US$ Million)
    • Rest of Latin America
    • Country Trends
    • Market Size and Forecast, By Product, 2014 - 2024 (US$ Million)
  • Middle East
    • Market Share Analysis, By Country, 2015 and 2024 (%)
    • Y-O-Y Growth Analysis, By Country, 2014 - 2024
    • GCC Countries
    • Country Trends
    • Market Size and Forecast, By Product, 2014 - 2024 (US$ Million)
    • Israel
    • Country Trends
    • Market Size and Forecast, By Product, 2014 - 2024 (US$ Million)
    • Rest of Middle East
    • Country Trends
    • Market Size and Forecast, By Product, 2014 - 2024 (US$ Million)
  • Africa
    • Market Share Analysis, By Country, 2015 and 2024 (%)
    • Y-O-Y Growth Analysis, By Country, 2014 - 2024
    • Northern Africa
    • Country Trends
    • Market Size and Forecast, By Product, 2014 - 2024 (US$ Million)
    • Central Africa
    • Country Trends
    • Market Size and Forecast, By Product, 2014 - 2024 (US$ Million)
    • South Africa
    • Country Trends
    • Market Size and Forecast, By Product, 2014 - 2024 (US$ Million)

6. Competitive Landscape

  • Heat Map Analysis
  • Company Profiles
    • Meda Pharmaceuticals, Inc
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Developments/Updates
    • Future Plans
    • Coloplast
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Developments/Updates
    • Future Plans
    • Global Life Technologies
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Developments/Updates
    • Future Plans
    • Reflexonic, LLC
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Developments/Updates
    • Future Plans
    • Augusta Medical System
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Developments/Updates
    • Future Plans
    • Boston Scientific Corporation
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Developments/Updates
    • Future Plans
    • Vivus, Inc
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Developments/Updates
    • Future Plans
  • Analyst Views

7. Section

  • References
  • Research Methodology
  • About us and Sales Contact
株式会社グローバルインフォメーション
© Copyright 1996-2020, Global Information, Inc. All rights reserved.